Current Status of Biopharmaceuticals: Approved Products and Trends in Approvals

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Biopharmaceuticals represent the fastestgrowing and, in many ways, the most excitingsector within the pharmaceutical industry.Within this Introduction we firstconsider what category of product fallswithin the description of a biopharmaceutical.An overall global snapshot of the currentstatus of the biopharmaceutical sectoris then presented, followed by an overviewof upstream and downstream processingoperations typical of protein-based biopharmaceuticals.General trends in product approvalsare next overviewed and this is followedby a summary of the main actualbiopharmaceutical products that havegained approval to date (within the EUand/or US). These are considered by producttype, the most significant of which areblood-related products, hormones, cytokines,vaccines and monoclonal antibodies.Biopharmaceuticals that have gained approvalfor veterinary application are thenconsidered, and the Introduction concludesby considering some of the innovationsand trends likely to influence theshape of the biopharmaceutical sector in the future.

Original languageEnglish
Title of host publicationModern Biopharmaceuticals
Subtitle of host publicationDesign, Development and Optimization
PublisherWiley-VCH Verlag GmbH
Pages1-34
Number of pages34
Volume1
ISBN (Print)352731184X, 9783527311842
DOIs
Publication statusPublished - 5 Feb 2008

Keywords

  • Aquired immunodeficiency syndrome
  • Baby hamster kidney
  • Erythropoietin
  • Eurifel
  • Hepatitis B surface antigen

Fingerprint

Dive into the research topics of 'Current Status of Biopharmaceuticals: Approved Products and Trends in Approvals'. Together they form a unique fingerprint.

Cite this